Elombah
Take a fresh look at your lifestyle.

BioNTech to present first quarter results

0

The German vaccine manufacturer BioNTech will on Monday  present its results for the first quarter of 2021.

In the past months the global demand for the COVID-19 vaccine produced by BioNTech with its U.S. partner Pfizer has transformed the firm’s financial figures.

In the fourth quarter, BioNTech booked a net profit of 366.9 million euros (446.2 million dollars), compared to a net loss of 58.2 million euros during the same quarter of the previous year.

But recent concerns about possibly losing patent rights have caused a stir among shareholders.

On April 5, the U.S. government surprisingly backed a global initiative to temporarily suspend patent rights on COVID-19 vaccines in order to promote the containment of the pandemic.

Other governments, for instance in Germany, oppose such a move, saying it would be unlikely to turbo-charge global production. (dpa/NAN)

Comments are closed.